Mapmyhealth announces successful ethical approval of Study MMD101. MMD101 is a feasibility of deployment study of Mapmydiabetes in patients with type 2 diabetes in Primary Care […]
Mapmyhealth joins the OxAHSN Network – and is already one of the Network’s exemplar innovations http://www.oxfordahsn.org/news-and-videos/news/new-partner-for-the-ahsn-mapmyhealth/
“Three million people in the UK have now been diagnosed with diabetes, says charity Diabetes UK, which warns this new high could create a huge burden […]
Mapmyhealth are awarded a feasibility grant under the Technology Strategy Board Biomedical Catalyst Award scheme to further their research and development efforts in type 2 diabetes
“The £180 million Biomedical Catalyst, announced by David Cameron in December 2011, will see the Medical Research Council and the Technology Strategy Board working together to […]
“Up to 24,000 diabetes-related deaths could be avoided in England each year, if patients and doctors better managed the condition” http://www.bbc.co.uk/news/health-16147731
“The health service could face a ‘diabetes time bomb’ according to an audit of patients in England and Wales” http://www.bbc.co.uk/news/health-13928359
Change is coming to the healthcare industry. Significant growth in ‘connected healthcare’ is going to create huge opportunities. In the UK, it could be worth as […]
Reacting to the announcement Dr Matthew Goodman from Mapmyhealth said: “We are deeply committed to improving diabetes care in the UK through the use of patient-facing […]
Mapmyhealth are delighted to be delivering Mapmydiabetes to patients with diabetes across the West of England in partnership with the WE AHSN within the NHS Test […]
“Here in Worcestershire we have recently seen the launch of Mapmydiabetes, an education tool enabling patients to take better control and self-manage their condition.” Diabetes diagnosis […]